Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06671704 · ClinicalTrials.gov registry record · NA
GC-PRO Intervention
A NA study of Cancer and Cardiovascular Diseases, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 994
- Enrollment target
- 1
- Study location
NCT06671704: Recruiting NA study of Cancer and Cardiovascular Diseases, sponsored by University of Minnesota.
NCT06671704 is a NA study of Cancer and Cardiovascular Diseases that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 994 participants, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06671704, a NA study of Cancer and Cardiovascular Diseases, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 994 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the GC-PRO study is to try to make genetic counseling better for people of all backgrounds. We are asking participants to complete two surveys and to allow audio recording of their genetic counseling visit. The purpose of the study is to understand whether trying different ways of doing genetic counseling will lead to better experiences for patients. The research team is also working with partners from the Somali, Latino/Hispanic, Black/African American, and Hmong communities to make sure the research is being done in a way that will benefit underserved communities.
Primary Outcome
The exact measure of effectiveness has been omitted to ensure no bias is created and that research integrity is preserved
Conditions Studied
Interventions
- OTHER Genetic counseling months 4-15
- OTHER Genetic counseling months 6-15
- OTHER Genetic counseling months 8-15
- OTHER Genetic counseling at months 10-15
- OTHER Genetic counseling at months 12-15
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 994 participants |
| Start Date | 2025-01-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06671704 shows while recruiting
NCT06671704 is an interventional study that assigns participants to a tested intervention. The registered 994 participants enrollment target is mid-sized for trials with a published cap, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (72% lower).
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Genetic counseling months 4-15 is the first listed.
NCT06671704 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06671704 about?
NCT06671704 is a clinical study titled "GC-PRO Intervention". The goal of the GC-PRO study is to try to make genetic counseling better for people of all backgrounds. We are asking participants to complete two surveys and to allow audio recording of their genetic counseling visit. The purpose of the study is to understand whether trying different ways of doing ...
What is the current status of trial NCT06671704?
This trial is currently recruiting. It is a NA study. The enrollment target is 994 participants. The study started on 2025-01-03. Estimated completion is 2026-06-30.
What conditions does trial NCT06671704 study?
This clinical trial studies the following conditions: Cancer, Cardiovascular Diseases, Prenatal Condition, Reproductive Condition, Genetic Condition.
What interventions are being tested in trial NCT06671704?
The interventions under investigation include: Genetic counseling months 4-15 (OTHER), Genetic counseling months 6-15 (OTHER), Genetic counseling months 8-15 (OTHER), Genetic counseling at months 10-15 (OTHER), Genetic counseling at months 12-15 (OTHER).
Who is sponsoring clinical trial NCT06671704?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06671704 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06671704's enrollment target sits among peer trials
994 87th of 615 higher than 528 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05437575 · 994 participants · Phase 3
Prehospital Analgesia INtervention Trial (PAIN)
- NCT05987241 · 992 participants · Phase 2
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI